BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3221917)

  • 1. Thomsen-Friedenreich (T)-active glycoproteins and a blood group N antigen precursor with T activity from human liver metastatic carcinomas.
    Otsuka K; Ohkuma S; Nakajima T; Kudo T
    Naturwissenschaften; 1988 Aug; 75(8):407-9. PubMed ID: 3221917
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas.
    Otsuka K; Kudo T; Nakajima T; Ohkuma S
    Int J Biochem; 1991; 23(5-6):569-78. PubMed ID: 1648519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and biochemical characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, T-active glycoproteins and N antigen precursor glycoproteins from ascites of primary ovarian cancer patients.
    Hayashi S; Ohyama K; Yanagi K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S
    Int J Biochem; 1990; 22(11):1315-24. PubMed ID: 2257955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thomsen-Friedenreich (T)-active glycoproteins, blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with T activity from ascitic fluids of liver cancer patients.
    Otsuka K; Nishida S; Yuasa H; Hara A; Shirai T; Ohkuma S
    Int J Biochem; 1991; 23(9):827-37. PubMed ID: 1663465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Separation of Thomsen-Friedenreich (T) antigen and N antigen precursor glycoproteins from perchloric acid-soluble fraction of cyst fluid of human ovarian clear cell carcinoma and their some chemical and serological properties].
    Yanagi K; Ohyama K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S
    Yakugaku Zasshi; 1990 Apr; 110(4):273-9. PubMed ID: 2165527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of Thomsen-Friedenreich antigen and prognosis of the patients with bladder tumor].
    Kobayashi H; Obata K; Andou M
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):674-9. PubMed ID: 3312742
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some chemical and serological properties of perchloric acid-soluble glycoproteins separated from ascitic fluid of a patient with metastatic omentum tumor from ovarian cancer].
    Kurihara M; Shimauchi S; Ohyama K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S
    Yakugaku Zasshi; 1990 Oct; 110(10):783-7. PubMed ID: 1963638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of tumor specific antigens in bladder cancer using anti Thomsen-Friedenreich monoclonal antibody and soybean agglutinin].
    Oda H; Oda T; Yokoyama M; Takeuchi M; Ohoka H; Utsumi S
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):713-8. PubMed ID: 3226022
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation and characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, N antigen precursor glycoproteins and T-active glycoproteins from cyst fluids of malignant ovarian clear cell carcinoma.
    Yanagi K; Ohyama K; Yamakawa T; Ohkuma S
    Int J Biochem; 1990; 22(9):1015-28. PubMed ID: 2282960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of a Vicia unijuga lectin-binding (Vgu) glycoprotein with Thomsen-Friedenreich (T) activity and Vgu glycoproteins in human primary hepatocellular carcinoma.
    Otsuka K; Mizuno M; Kagawa K; Kashima K; Ohkuma S
    Int J Biochem; 1992 Sep; 24(9):1407-19. PubMed ID: 1330763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tn epitopes, immunoreactive with ordinary anti-Tn antibodies, on normal, desialylated human erythrocytes and on Thomsen-Friedenreich antigen isolated therefrom.
    Springer GF; Desai PR
    Mol Immunol; 1985 Nov; 22(11):1303-10. PubMed ID: 2417112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Vicia graminea lectin- or Vicia unijuga lectin-binding (Vgu) glycoproteins, Vgu glycoproteins with Thomsen-Friedenreich (T) activity and T-active glycoproteins in human meconium.
    Uchide N; Ohyama K; Yamakawa T; Ohkuma S
    Int J Biochem Cell Biol; 1995 Mar; 27(3):319-27. PubMed ID: 7780836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen.
    Seitz RC; Fischer K; Stegner HE; Poschmann A
    Cancer; 1984 Sep; 54(5):830-6. PubMed ID: 6331628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tandem enzymatic approach for detecting and imaging tumor-associated Thomsen-Friedenreich antigen disaccharide.
    Li Q; Li Z; Duan X; Yi W
    J Am Chem Soc; 2014 Sep; 136(36):12536-9. PubMed ID: 25157422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS; Miller AW; Coon JS
    Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and characterization of a Vicia graminea and Vicia unijuga lectins-binding (Vgu) glycoprotein with Thomsen-Friedenreich (T) activity from human liver metastases of pancreas carcinoma.
    Ueno E; Otsuka K; Kudo T; Ohkuma S
    Int J Biochem; 1992 May; 24(5):769-76. PubMed ID: 1592152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas. A reevaluation.
    Cao Y; Karsten UR; Liebrich W; Haensch W; Springer GF; Schlag PM
    Cancer; 1995 Nov; 76(10):1700-8. PubMed ID: 8625037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical implication of serum antibody to Thomsen-Friedenreich antigen in patients with gynecological malignancies].
    Yasui T; Sakamoto Y; Ueda T; Maeda N; Shitsukawa K; Furumoto H; Mori K; Daitoh T; Irahara M; Kamada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):583-7. PubMed ID: 3385276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca antigen is not Thomsen-Friedenreich antigen.
    Harris H; Bramwell ME; McGee JO
    Lancet; 1982 Oct; 2(8304):925-6. PubMed ID: 6126765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.